12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

  • Sonnet BioTherapeutics SONN stock moved upwards by 20.91% to $0.68 during Monday's after-market session. Today's trading volume for this security ended up closing at 9.8 million shares, which is 173.27 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $16.8 million.
  • Cellect Biotechnology APOP shares rose 5.63% to $5.25. At the close, Cellect Biotechnology's trading volume reached 584.8K shares. This is 32.94% of its average volume over the last 100 days. The company's market cap stands at $20.5 million. As per the news, the Q2 earnings report came out 4 days ago.
  • F-star Therapeutics FSTX shares increased by 4.45% to $7.74. The market value of their outstanding shares is at $159.5 million.
  • Diffusion Pharmaceuticals DFFN stock rose 3.94% to $0.63. Today's trading volume for this security ended up closing at 201.9K shares, which is 13.64 percent of its average volume over the last 100 days. The company's market cap stands at $64.2 million.
  • Alterity Therapeutics ATHE stock rose 3.73% to $1.39. The market value of their outstanding shares is at $55.7 million.
  • Galapagos GLPG shares moved upwards by 3.71% to $57.01. The company's market cap stands at $3.7 billion.

Losers

  • Organovo Holdings ONVO stock fell 4.45% to $7.1 during Monday's after-market session. The company's market cap stands at $61.8 million.
  • Biotricity BTCY shares fell 3.53% to $3.01. The market value of their outstanding shares is at $126.8 million.
  • Acer Therapeutics ACER shares fell 3.17% to $2.45. The company's market cap stands at $35.0 million.
  • Bio-Path Holdings BPTH shares decreased by 1.98% to $5.46. The market value of their outstanding shares is at $38.0 million.
  • Mednax MD shares declined by 1.97% to $34.5. Trading volume for this security closed at 57.8K, accounting for 11.56% of its average full-day volume over the last 100 days. The company's market cap stands at $2.9 billion.
  • Gemini Therapeutics GMTX shares decreased by 1.72% to $4.0. The company's market cap stands at $172.4 million.

Posted In: BZI-TFMMovers